Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Ansan Hospital, Ansan, Republic of Korea.
J Int Adv Otol. 2022 Sep;18(5):415-419. doi: 10.5152/iao.2022.21360.
Two-stage ossiculoplasty has been widely used for hearing improvement in chronic otitis media with or without cholesteatoma. However, the outcomes of single-stage ossiculoplasty have not been fully clarified.The aim of this study is to determine whether the outcomes of single-stage ossiculoplasty are comparable with those of 2-stage ossiculoplasty in chronic otitis media with or without cholesteatoma.
Medical records of 191 cases (187 patients) who underwent single-stage ossiculoplasty from January 2011 to May 2018 at our hospital were retrospectively reviewed.
Polycel and titanium were used in 56 and 135 cases, respectively. In chronic otitis media without cholesteatoma, the success rate of polycel and titanium partial ossicular replacement prosthesis was 80.7% and 81.6%, respectively. In chronic otitis media with cholesteatoma, the success rate of polycel and titanium partial ossicular replacement prosthesis was 63.6% and 64.6%, respectively, while that of polycel and titanium total ossicular replacement prosthesis was 45.9% and 47.8%, respectively.
These results suggest that single-stage ossiculoplasty is a suitable option for recovering postoperative hearing in chronic otitis media with or without cholesteatoma. Thus, if middle ear inflammation can be sufficiently treated in the first stage, single-stage ossiculoplasty is a suitable option for chronic otitis media with or without cholesteatoma.
对于慢性中耳炎伴或不伴胆脂瘤患者,两阶段式听小骨重建术已被广泛用于改善听力。然而,单阶段式听小骨重建术的结果尚未完全阐明。本研究旨在确定在慢性中耳炎伴或不伴胆脂瘤患者中,单阶段式听小骨重建术的结果是否与两阶段式听小骨重建术相当。
回顾性分析了 2011 年 1 月至 2018 年 5 月在我院行单阶段式听小骨重建术的 191 例(187 例患者)的病历资料。
在慢性中耳炎不伴胆脂瘤中,聚碳酸酯和钛质部分听小骨重建假体的成功率分别为 80.7%和 81.6%。在慢性中耳炎伴胆脂瘤中,聚碳酸酯和钛质部分听小骨重建假体的成功率分别为 63.6%和 64.6%,而聚碳酸酯和钛质全听小骨重建假体的成功率分别为 45.9%和 47.8%。
这些结果表明,单阶段式听小骨重建术是治疗慢性中耳炎伴或不伴胆脂瘤患者术后听力恢复的一种合适选择。因此,如果在第一阶段能够充分治疗中耳炎症,单阶段式听小骨重建术是慢性中耳炎伴或不伴胆脂瘤的一种合适选择。